The safety and efficacy of erlotinib have not been founded for patients with NSCLC whose tumors exhibit other EGFR mutations. Furthermore it is not suggested to be used together with platinum-based chemotherapy. Label Erlotinib or gefitinib coupled with chemotherapy as initial-line therapy for patients with non-smaller cell lung cancer. ), https://russello888dpb1.wikififfi.com/user